Ambio Life Sciences

Ambio Life Sciences is a treatment provider operating in Mexico that offers ibogaine administration to international clients, including military veterans. It is one of the providers most frequently named in contemporary coverage of ibogaine treatment and appears in published accounts of veteran cohorts who traveled abroad for treatment, including participants later assessed by academic researchers. The organization states that it screens clients medically before administration and monitors cardiac function during treatment, and it has publicly described collaboration with outside researchers on data collection. Its position in the field reflects the wider structure of the ibogaine space: because ibogaine is a Schedule I substance in the United States, clinical administration takes place in jurisdictions where the compound is unscheduled or unregulated, and providers in Mexico account for a large share of documented treatment episodes. Independent regulatory oversight of ibogaine clinics in Mexico is limited, and there is no public accreditation body for the sector, so claims about protocols and outcomes generally originate with providers themselves rather than with external inspectors. Nothing in this summary should be read as a statement about the effectiveness or the safety of treatment offered by this or any other provider.